96
Participants
Start Date
June 15, 2015
Primary Completion Date
March 31, 2026
Study Completion Date
March 31, 2026
Molecular Breast Imaging (MBI)
Participants undergo 3 MBI scans with injections of injection of Tc99m sestamibi before each scan. First scan is 7 days before scheduled neoadjuvant chemotherapy (NAC) treatment, after 2 cycles of chemotherapy, and after completion of chemotherapy treatment.
Tc99m sestamibi
8 mCi of 99mTc sestamibi by vein before each molecular breast imaging (MBI).
University of Texas MD Anderson Cancer Center, Houston
M.D. Anderson Cancer Center
OTHER